Evaluation of a Single-Tube Multiplex Polymerase Chain Reaction Screen for Detection of Common alpha-Thalassemia Genotypes in a Clinical Laboratory
Authors:
- Alana K. Bergstrome JonesAJAlana K. Bergstrome Jones
- Annette PoonAPAnnette Poon
Open Access
- 1 July 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 118 (1) , 18-24
Abstract
We prospectively compared a single-tube multiplex polymerase chain reaction (PCR) for detecting alpha-thalassemia with our current approach using 452 blood samples. Initial evaluation of 89 specimens revealed sensitivity and specificity, respectively, for the hemoglobin H inclusion body test (HbH prep) vs PCR for detecting alpha0-thalassemia carriers of 0.79 and 0.96 and for a mean corpuscular volume (MCV) of 82 μm3 (82 fL) or less, 1.0 and 0.45. Detection of all alpha-thalassemia genotypes was significantly lower for HbH prep and MCV (sensitivity and specificity, respectively: HbH prep, 0.48 and 0.96; MCV, 0.87 and 0.47). In a follow-up evaluation of patients with positive HbH prep results or suspected alpha-thalassemia prescreened by low MCV, the sensitivity and specificity, respectively, of HbH prep vs PCR increased to 0.97 and 0.93 for alpha0-thalassemia and 0.83 and 0.92 for any alpha-thalassemia. PCR detected alpha-thalassemia in 37.2% of 298 suspected alpha-thalassemia cases with suggestive indices but negative HbH prep results and no detectable hemoglobinopathy. This multiplex approach was more sensitive than the HbH prep for detecting all alpha-thalassemia genotypes, particularly alpha+-thalassemia; was particularly valuable for identifying carriers of alpha0-thalassemia at risk for offspring with hemoglobin Bart hydrops fetalis, regardless of other diagnosed hemoglobinopathies; and is an ideal adjunct to standard clinical screening protocols for detecting alpha-globin deletions.Keywords
This publication has 13 references indexed in Scilit:
- Universal Newborn Screening for Hb H Disease in CaliforniaGenetic Testing, 2001
- Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fL in areas with a high prevalence of thalassaemia?Journal of Clinical Pathology, 2001
- α‐Thalassaemia as a result of a novel splice donor site mutation of the α1‐globin geneBritish Journal of Haematology, 2000
- Rapid detection of α‐thalassaemia deletions and α‐globin gene triplication by multiplex polymerase chain reactionsBritish Journal of Haematology, 2000
- Molecular, haematological and clinical studies of the −101 C → T substitution of the β‐globin gene promoter in 25 β‐thalassaemia intermedia patients and 45 heterozygotesBritish Journal of Haematology, 1999
- Unexpected pattern of beta-globin mutations in beta-thalassaemia patients from northern PortugalBritish Journal of Haematology, 1999
- A reverse dot‐blot method for rapid detection of non‐deletion α thalassaemiaBritish Journal of Haematology, 1999
- Frequency of Deletional α-Thalassemia Genotypes in a Predominantly Asian-American PopulationAmerican Journal of Clinical Pathology, 1997
- Rapid detection of −α 4.2 deletion of α-thalassemia-2 by polymerase chain reactionAnnals of Hematology, 1994
- Detection of common deletional α‐thalassemia‐2 determinants by PCRAmerican Journal of Hematology, 1994